Ludovico Guarini MD Pediatric Hematology Residency Beth Isreal Medical Center .. Fellowship: Coulmbia University .. Director of Pediatric Hematology at Maimonides Medical Center .. Castle Connolly Top Doctor .. DrMDK.com
Read the full transcript »

Host: So there is great hope down the road? Dr. Ludovico Guarini: It is great hope in this rare disease. Also there are for instance, further interventions that they have changed the face of the sickle cell, including the use of hydroxyurea. Hydroxyurea is a medication that, it was used actually as cancer treatment for a long time but it has a very good track record of being used in a chronic and a longterm kind of situation and without significant side effects and there was a very pivotal study about -- it's getting close to 15 years where hydroxyurea was used to see whether or not it could prevent some of the complications of the sickle cell and it does. And a number of patients nowadays, both adults and pediatric patients are on hydroxyurea and that has made their life incredibly better. Host: Thank you Dr. Ludovico Guarini.

Advertisement
Advertisement
Advertisement